Pleo Ex (Sanum Kehlbeck GmbH & Co. KG)


Welcome to the PulseAid listing for the Pleo Ex drug offered from Sanum Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanum Kehlbeck GmbH & Co. KG
NON-PROPRIETARY NAME: candida albicans, candida parapsilosis, and penicillium roqueforti
SUBSTANCE NAME: CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-06-15
END MARKETING DATE: 0000-00-00


Pleo Ex HUMAN OTC DRUG Details:

Item DescriptionPleo Ex from Sanum Kehlbeck GmbH & Co. KG
LABELER NAME: Sanum Kehlbeck GmbH & Co. KG
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 5; 5([hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL)
START MARKETING DATE: 2010-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60681-1003_5ac916ec-8252-4e53-8009-3cfb42347074
PRODUCT NDC: 60681-1003
APPLICATION NUMBER:

Other CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanum Kehlbeck GmbH & Co. KGPleo Ex